Features of regional relapses in the central zone after surgical treatment of highly differentiated thyroid cancer

Introduction. Thyroid cancer is the most common malignant tumor of the endocrine system and comprises 33 % of malignant neoplasms of the head and neck. first echelon lymph nodes affected by this pathology are located in the central area of the neck. The metastatic process further advances into the lymph nodes in the lateral tissues of the neck. Currently, there is no consensus on the effectiveness of prophylactic central lymph node dissection and no conclusive criteria determining the risk of recurrence in the central zone.

Aim. The assessment of factors influencing the risk of regional recurrence in the central zone.

Materials and methods. The study included 30 patients with highly differentiated thyroid cancer, in whom metastatic nodes in the central zone were identified and verified during primary treatment. All patients previously underwent unilateral or 2-sided central lymph node dissection in various institutions. During the period of dynamic observation, these patients revealed regional recurrence in the central zone. patients were observed and treated for recurrence at the National medical Research Center of Oncology named after N.N. Blokhin of the ministry of Health of Russia.

Results. primary surgical treatment in a specialized oncological institution was performed in 21 (70 %) patients, in a general surgical medical institution – in 7 (23.3 %), in an endocrinological institution – in 2 (6.7 %) patients. when assessing the influence of the morphological type and variant of thyroid cancer on the risk of developing regional recurrence,  no  statistical  significance  was  found.  No  statistically  significant  factors  were  found  in  the  analysis  of  the influence of characteristics of the primary tumor, such as tumor size, multifocal lesion, vascular invasion, extrathyroidal spread, on the risk of regional recurrence. In 16 (53.3 %) patients, recurrence occurred in the paratracheal zone of the ipsilateral side, in 7 (23.3 %) patients in the paratracheal zone of the contralateral side, bilateral lesions were observed in 2 (6.67 %) cases. 3 (10 %) patients were diagnosed with transient parathyroid insufficiency, 1 (3.3 %) – permanent parathyroid insufficiency, 1 (3.3 %) – hematoma in the area of the postoperative wound, patient, 2 (6.6 %) – injury to the recurrent laryngeal nerve.

Conclusion. Residual metastatic lymph nodes after previous surgical treatment are the reason for performing a second operation, which carries both the risks of postoperative complications and the psychological burden on the patient. Thus, an adequate and radically performed primary surgical intervention is the key to reducing regional recurrences.

1. Lundgren C.I., Hall P., Dickman P.W., Zedenius J. Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 2006;106(3):524–31. DOI: 10.1002/cncr.21653

2. Sherman S.I. Thyroid carcinoma. Lancet 2003;361(9356):501–11. DOI: 10.1016/s0140-6736(03)12488-9

3. Asimakopoulos P., Nixon I.J., Shaha A.R. Differentiated and Medullary Thyroid Cancer: Surgical Management of Cervical Lymph Nodes. Clin Oncol 2017;29(5):283–9. DOI: 10.1016/j.clon.2017.01.001

4. Tiroidin Fonksiyonel ve Cerrahi Anatomisi. Ed. by A. Isgör, M. Uludağ, A. Isgör, M. Uludağ. Tiroit. 1st edn. Istanbul: Nobel Tip Kitabevleri, 2013. Pp. 775–800.

5. Kouvaraki M.A., Shapiro S.E., Fornage B.D. et al. Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 2003;134(6):946–54. DOI: 10.1016/s0039-6060(03)00424-0

6. 6Chow S.M., Law S.C., Chan J.K. et al. Papillary microcarcinoma of the thyroid-prognostic significance of lymph node metastasis and multifocality. Cancer 2003;98(1):31–40. DOI: 10.1002/cncr.11442

7. Shaha A.R. Prophylactic central compartment dissection in thyroid cancer: a new avenue of debate. Surgery 2009;46(6):1224–7. DOI: 10.1016/j.surg.2009.10.020

8. Sugitani I., Kasai N., Fujimoto Y., Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 2004;135(2):139–48. DOI: 10.1016/s0039-6060(03)00384-2

9. Snow G.B., Patel P., Leemans C.R., Tiwari R. Management of cervical lymph nodes in patients with head and neck cancer. Eur Arch Otorhinolaryngol 1992;249(4):187–94. DOI: 10.1007/BF00178467

10. Moo T.A., McGill J., Allendorf J. et al. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma. World J Surg 2010;34(6):1187–91. DOI: 10.1007/s00268-010-0418-3

11. Forest V.I., Clark J.R., Ebrahimi A. et al. Central compartment dissection in thyroid papillary carcinoma. Ann Surg 2011;253(1):123–30. DOI: 10.1097/SLA.0b013e3181fc9644

12. Amin M.B., Greene F.L., Edge S.B. et al. The Eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 2017;67(2):93–9. DOI: 10.3322/caac.21388

13. Cooper D.S., Doherty G.M., Haugen B.R. et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19(11):1167–214.

14. Carty S.E., Cooper D.S., Doherty G.M. et al. Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 2009;19(11):1153–8. DOI: 10.1089/thy.2009.0159

15. Haugen B.R., Alexander E.K., Bible K.C. el al. American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133. DOI: 10.1089/thy.2015.0020

16. Takami H., Ito Y., Okamoto T., Yoshida A. Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 2010;35(1):111–21. DOI:10.1007/s00268-010-0832-6

17. British Thyroid Association. Guidelines for the management of thyroid cancer, 2nd edn. 2007. Available at: http://www.british-thyroidassociation.org/news/Docs/Thyroid_cancer_guidelines_2007.pdf

18. Adam M.A., Pura J., Gu L. et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 2014;260(4):601–5. DOI: 10.1097/SLA.0000000000000925

19. Nixon I.J., Wang L.Y., Ganly I. et al. Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection. Br J Surg 2016;103(3):218–25. DOI: 10.1002/bjs.10036

20. Zhao W., You L., Hou X. et al. The effect of prophylactic central neck dissection on locoregional recurrence in papillary thyroid cancer after total thyroidectomy: a systematic review and meta-analysis: pCND for the locoregional recurrence of papillary thyroid cancer. Ann Surg Oncol 2017;24(8):2189–98. DOI: 10.1245/s10434-016-5691-4

21. Chen L., Wu Y.H., Lee C.H. et al. Prophylactic central neck dissection for papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes: a systematic review and meta-analysis. World J Surg 2018;42(9):2846–57. DOI: 10.1007/s00268-018-4547-4

22. Zhao W.J., Luo H., Zhou Y.M. et al. Evaluating the effectiveness of prophylactic central neck dissection with total thyroidectomy for cN0 papillary thyroid carcinoma: an updated meta-analysis. Eur J Surg Oncol 2017;43(11):1989–2000. DOI: 10.1016/j.ejso.2017.07.008

23. Su H., Li Y. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis. Braz J Otorhinolaryngol 2019;85(2):237–43. DOI: 10.1016/j.bjorl.2018.05.004

24. Raffaelli M., Crea C.D., Sessa L. et al. Prospective evaluation of total thyroidectomy versus ipsilateral versus bilateral central neck dissection in patients with clinically node-negative papillary thyroid carcinoma. Surgery 2012;152(6):957–64. DOI: 10.1016/j.surg.2012.08.053

25. Dobrinja C., Troian M., Cipolat M.T. et al. Rationality in prophylactic central neck dissection in clinically node-negative (Cn0) papillary thyroid carcinoma: is there anything more to say? A decade experience in a single-center. Int J Surg 2017;41(Suppl. 1):S40–7. DOI: 10.1016/j.ijsu.2017.01.113

26. Kim S.K., Woo J.W., Lee J.H. et al. Prophylactic central neck dissection might not be necessary in papillary thyroid carcinoma: analysis of 11,569 cases from a single institution. J Am Coll Surg 2016;222(5):853–64. DOI: 10.1016/j.jamcollsurg.2016.02.001

27. Viola D., Materazzi G., Valerio L. et al. Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab 2015;100(4):1316–24. DOI: 10.1210/jc.2014-3825

28. White M.L., Doherty G.M. Level VI lymph node dissection for papillary thyroid cancer. Minerva Chir 2007;62(5):383–93.

29. Raffaelli M., Crea C.D., Sessa L. et al. Modulating the extension of thyroidectomy in patients with papillary thyroid carcinoma preoperatively eligible for lobectomy: reliability of ipsilateral central neck dissection. Endocrine 2021;72(2):437–44. DOI: 10.1007/s00268-013-2089-3

30. Hartl D.M., Mamelle E., Borget I. et al. Influence of prophylactic neck dissection on rate of retreatment for papillary thyroid carcinoma. World J Surg 2013;37(8):1951–8. DOI: 10.1007/s00268-013-2089-3

31. Eun Y.G., Lee Y.C., Kwon K.H. Predictive factors of contralateral paratracheal lymph node metastasis in papillary thyroid cancer: prospective multicenter study. Otolaryngol Head Neck Surg 2014;150(2):210–5. DOI: 10.1177/0194599813514726

32. Lee K.E., Chung I.Y., Kang E. et al. Ipsilateral and contralateral central lymph node metastasis in papillary thyroid cancer: patterns and predictive factors of nodal metastasis. Head Neck 2013;35(5):672–6. DOI: 10.1002/hed.23016

33. Koo B.S., Choi E.C., Yoon Y.H. et al. Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg 2009;249(5):840–4. DOI: 10.1097/SLA.0b013e3181a40919

34. Chen Q., Liu Y., Lu W. et al. Pretracheal lymph node subdivision in predicting contralateral central lymph node metastasis for unilateral papillary thyroid carcinoma: preliminary results. Front Endocrinol (Lausanne) 2022;13:921845. DOI: 10.3389/fendo.2022.921845

35. Wei T., Chen R., Zou X. et al. Predictive factors of contralateral paratracheal lymph node metastasis in unilateral papillary thyroid carcinoma. Eur J Surg Oncol 2015;41(6):746–50. DOI: 10.1016/j.ejso.2015.02.013

36. Yoo H.S., Shin M.C., Ji Y.B. et al. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: comparison of unilateral versus bilateral central neck dissection. Asian J Surg 2018;41(4):363–9. DOI: 10.1016/j.asjsur.2017.03.002

37. Loyo M., Tufano R.P., Gourin C.G. National trends in thyroid surgery and the effect of volume on short-term outcomes. Laryngoscope 2013;123(8):2056–63. DOI: 10.1002/lary.23923

38. Sosa J.A., Bowman H.M., Tielsch J.M. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998;228(3):320–30. DOI: 10.1097/00000658-199809000-00005

39. Schneider D.F., Ojomo K.A., Chen H., Sippel R.S. Remnant uptake as a postoperative oncologic quality indicator. Thyroid 2013;23(10):1269–76. DOI: 10.1089/thy.2012.0451

40. Popadich A., Levin O., Lee J.C. et al. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer. Surgery 2011;150(6):1048–57. DOI: 10.1016/j.surg.2011.09.003

41. Leboulleux S., Rubino C., Baudin E. et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 2005;90(10):5723–9. DOI: 10.1210/jc.2005-0285